Danaher Receives Consensus Rating of “Buy” from Brokerages (NYSE:DHR)
Shares of Danaher (NYSE:DHR) have been given a consensus rating of “Buy” by the seventeen brokerages that are currently covering the stock, Stock Ratings News reports. Four research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $73.07.
Shares of Danaher (NYSE:DHR) opened at 77.04 on Monday. Danaher has a 1-year low of $64.78 and a 1-year high of $81.14. The stock’s 50-day moving average is $75.84 and its 200-day moving average is $76.04. The company has a market cap of $53.981 billion and a P/E ratio of 20.79.
Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, July 17th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.01. The company had revenue of $5.00 billion for the quarter, compared to the consensus estimate of $4.97 billion. During the same quarter in the previous year, the company posted $0.87 earnings per share. The company’s revenue for the quarter was up 4.8% on a year-over-year basis. On average, analysts predict that Danaher will post $3.67 earnings per share for the current fiscal year.
A number of analysts have recently weighed in on DHR shares. Analysts at Zacks reiterated a “neutral” rating on shares of Danaher in a research note on Friday, August 8th. They now have a $78.00 price target on the stock. Separately, analysts at Robert W. Baird raised their price target on shares of Danaher from $40.00 to $41.00 in a research note on Friday, August 1st. They now have an “outperform” rating on the stock. Finally, analysts at Barclays raised their price target on shares of Danaher from $80.00 to $83.00 in a research note on Friday, July 18th.
Danaher Corporation (NYSE:DHR) designs, manufactures and markets professional, medical, industrial and commercial products and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.